News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Hidehito Horinouchi: Impact of Durvalumab on corticosteroid therapy for pneumonitis after chemoradiotherapy
Photo taken from Hidehito Horinouchi/X
Aug 13, 2024, 20:25

Hidehito Horinouchi: Impact of Durvalumab on corticosteroid therapy for pneumonitis after chemoradiotherapy

Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, shared on X:

“Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After Chemoradiotherapy.

Saori Murata, Hidehito Horinouchi, Clinical Lung Cancer.

Representation of duration and complexity of tapering patterns.”

Hidehito Horinouchi

Source: Hidehito Horinouchi/X

Impact of Durvalumab on the Duration and Complexity of Corticosteroid Therapy for Pneumonitis After Chemoradiotherapy.

Authors: Saori Murata, Hidehito Horinouchi, Momoko Morishita, Sawako Kaku, Yuki Shinno, Yusuke Okuma, Tatsuya Yoshida, Yasushi Goto, Noboru Yamamoto, Tairo Kashihara, Kae Okuma, Masahiko Kusumoto, and Yuichiro Ohe.

Hidehito Horinouchi

cancer Clinical Lung Cancer Corticosteroid Therapy Durvalumab Hidehito Horinouchi Kae Okuma Masahiko Kusumoto Momoko Morishita Noboru Yamamoto OncoDaily Oncology pneumonitis Saori Murata Sawako Kaku Tairo Kashihara Tatsuya Yoshida Yasushi Goto Yuichiro Ohe Yuki Shinno Yusuke Okuma
Special Coverage
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer
Science
Dec 21, 2024, 07:05
Naseema Gangat: Practical prognostic tool for the current standard of care in older/unfit AML
Blog
Dec 21, 2024, 05:54
LCC in Spanish: LALCA 2024 Highlights
Blog
Dec 21, 2024, 05:50
The Opportunities Are Endless: CU Cancer Center leader Enrique Soto Pérez de Celis signs key international agreement
Insight
Dec 21, 2024, 05:42
Raffaella Casolino: How to integrate cancer into crisis?
Insight
Dec 21, 2024, 05:01
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Blog
Dec 21, 2024, 05:01
Omolola Salako: A year ago, Pearl Oncology Specialist Hospital became a 24-hour, 10-bed cancer center
Science
Dec 21, 2024, 04:57
Alexandre Chan: Updates on repurposing riluzole as a treatment for cancer-related cognitive impairment
Blog
Dec 21, 2024, 04:55
Milan Mishkovikj: The Patient at the Center - Value-Based Healthcare in Oncology
Insight
Dec 21, 2024, 04:52
Do national cancer control plans address care and research for children and AYAs - SIOP
Insight
Dec 21, 2024, 04:36
A holistic global strategy for incorporating cancer care into crisis response initiatives - The Institute of Cancer and Crisis
Opinion
Dec 21, 2024, 03:42
The Dorcas Cancer Foundation's 12 Days of Thankful Giving